Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
CA 2466152 A1 · Owner: Haviv, Fortuna · Inventors: Haviv, Fortuna; Bradley, Michael F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3) which are useful for , treating conditions that arise from or are exacerbated by angiogenesis are , described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds and methods of , inhibiting angiogenesis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 30, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.